Comparison of risedronate versus placebo in preventing anastrozole-induced bone loss in women at high risk of developing breast cancer with osteopenia
Journal article published in 2019 by
Ivana Sestak 
,
Glen M. Blake,
Rajesh Patel,
Robert E. Coleman,
Jack Cuzick,
Richard Eastell
,
Glen M. Blake,
Rajesh Patel,
Robert E. Coleman,
Jack Cuzick,
Richard Eastell
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 